Callitas Health Inc. Share Price Deutsche Boerse AG
Equities
T3F3
CA13125C1068
Biotechnology & Medical Research
Sales 2018 | 0.75 0.7 62.6 | Sales 2019 | 0.71 0.66 59.18 | Capitalization | 3.53M 3.3M 294M |
---|---|---|---|---|---|
Net income 2018 | -5M -4.69M -417M | Net income 2019 | -1M -937K -83.46M | EV / Sales 2018 | 48,52,616 x |
Net Debt 2018 | 319K 299K 26.62M | Net Debt 2019 | 848K 794K 70.74M | EV / Sales 2019 | 61,68,166 x |
P/E ratio 2018 |
-0.6
x | P/E ratio 2019 |
-1.97
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 72.04% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 03/18/03 | |
Robert Payment
DFI | Director of Finance/CFO | 42 | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Donald Skeith
BRD | Director/Board Member | 69 | 01/14/01 |
William Rodgers
BRD | Director/Board Member | - | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
1st Jan change | Capi. | |
---|---|---|
+0.17% | 42.19B | |
+10.92% | 42.24B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.23% | 24.63B | |
-24.79% | 18.2B | |
+26.69% | 12.01B | |
-3.13% | 11.76B | |
+6.57% | 10.4B |